| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |